Clinical Trial Update: Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on the immunogenicity, safety and reactogenicity of the combined DTPa-IPV vaccine in healthy infants; results posted after complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acellular Pertussis
• Diphtheria
• Tetanus

Drugs mentioned

• DTPa-IPV vaccine (Diphtheria, Tetanus, and Acellular Pertussis combined with Inactivated Poliovirus Vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tetanus, Acellular Pertussis | Phase 3 | Status: COMPLETED | Results posted: 2018-10-29